Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety and effectiveness of VELCADE® in the
treatment of acute graft-versus-host disease (GVHD) that has not responded to steroids or has
worsened when the steroid dose was decreased. VELCADE® is a drug that inhibits certain immune
reactions that happen when lymphocytes encounter foreign substances. We are doing this
research to determine if VELCADE® may be useful in treating GVHD.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University